Response letter to the editor

Comment

Siri Atma Greeley. J Clin Endocrinol Metab. 2015 Jan.

. 2015 Jan;100(1):L14.

doi: 10.1210/jc.2014-4089.

No abstract available

Comment on

Sulfonylurea treatment before genetic testing in neonatal diabetes: pros and cons.
Carmody D, Bell CD, Hwang JL, Dickens JT, Sima DI, Felipe DL, Zimmer CA, Davis AO, Kotlyarevska K, Naylor RN, Philipson LH, Greeley SA. Carmody D, et al. J Clin Endocrinol Metab. 2014 Dec;99(12):E2709-14. doi: 10.1210/jc.2014-2494. J Clin Endocrinol Metab. 2014. PMID: 25238204 Free PMC article.
Letter to the editor: recent advances in genetic testing and treatment of neonatal diabetes mellitus.
Aydın BK, Darendeliler F. Aydın BK, et al. J Clin Endocrinol Metab. 2015 Jan;100(1):L13. doi: 10.1210/jc.2014-3808. J Clin Endocrinol Metab. 2015. PMID: 25559538 No abstract available.

1. Ellard S, Lango Allen H, De Franco E, et al. . Improved genetic testing for monogenic diabetes using targeted next-generation sequencing. Diabetologia. 2013;56:1958–1963. - PMC - PubMed
1. Bonnefond A, Philippe J, Durand E, et al. . Highly sensitive diagnosis of 43 monogenic forms of diabetes or obesity through one-step PCR-based enrichment in combination with next-generation sequencing. Diabetes Care. 2014;37:460–467. - PubMed
1. Alkorta-Aranburu G, Carmody D, Cheng YW, et al. . Phenotypic heterogeneity in monogenic diabetes: the clinical and diagnostic utility of a gene panel-based next-generation sequencing approach [published online September 28, 2014]. Mol Genet Metab. doi: 10.1016/j.ymgme.2014.09.007. - DOI - PMC - PubMed
1. Greeley SA, John PM, Winn AN, et al. . The cost-effectiveness of personalized genetic medicine: the case of genetic testing in neonatal diabetes. Diabetes Care. 2011;34:622–627. - PMC - PubMed